Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a first-in-class non-opioid analgesic—to treat moderate to severe acute pain in adults.

This approval is considered a major breakthrough in treating acute pain without the need for opioid medication as reliance on ...

Opioids are a class of drugs that “derive from, or mimic, natural substances found in the opium poppy plant”, according to the website of the US-based Johns Hopkins Medicine. Some common opioids ...

The FDA has approved Journavx, a new non-opioid painkiller by Vertex Pharmaceuticals. It offers post-surgical pain relief without addiction risks but is less effective than opioids. With a high cost ...

Videos of people including teens inhaling the nitrous oxide from Galaxy Gas to get high have been appearing on TikTok, ...

University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage.

Consisting of five separate booklets, the World Drug Report 2022 provides an in-depth analysis of global drug markets and examines the nexus between drugs and the environment within the bigger picture ...